Retinoic acid fails to reverse emphysema in adult mouse models.
BACKGROUND
Previous work has shown that all-trans-retinoic acid reverses elastase induced emphysema in rats. Since there is currently no effective treatment for pulmonary emphysema, the effect of retinoic acid should be further investigated in other adult species. A study was undertaken using two murine models of emphysema to evaluate the effect of retinoic acid.


METHODS
The models used were an elastase induced emphysema model for acute alveolar destruction and a tumour necrosis factor (TNF)-alpha transgenic mouse which exhibits chronic air space enlargement, loss of elastic recoil, increased lung volume, and pulmonary hypertension comparable to human pulmonary emphysema. All-trans-retinoic acid (2 mg/kg) was injected for 12 successive days after the establishment of emphysema. The effects of treatment were evaluated using physiological and morphometric analyses.


RESULTS
In contrast to the rat, administration of all-trans-retinoic acid in these murine models did not improve the emphysema. Moreover, worsening of emphysema was observed in TNF-alpha transgenic mice treated with all-trans-retinoic acid. The level of keratinocyte chemoattractant (KC), a CXC chemokine, in bronchoalveolar lavage fluid was increased in TNF-alpha transgenic mice following retinoic acid treatment. These data raise the possibility that retinoic acid causes deterioration of emphysema by promoting inflammation in this model.


CONCLUSIONS
In these models, retinoic acid did not show positive effects on emphysema. The effect of retinoic acid in the treatment of pulmonary emphysema remains controversial, and further studies are required to determine its physiological effects under a variety of experimental conditions.
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. fujita@kokyu.med.kyushu-u.ac.jp
M
M
Fujita
Q
Q
Ye
H
H
Ouchi
N
N
Nakashima
N
N
Hamada
N
N
Hagimoto
K
K
Kuwano
R J
RJ
Mason
Y
Y
Nakanishi
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D018925:Chemokines / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D045726:Metalloproteases / Q000032:analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D010196:Pancreatic Elastase / Q000633:toxicity; D011656:Pulmonary Emphysema / Q000188:drug therapy* / Q000473:pathology; D014212:Tretinoin / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000633:toxicity
D018925:Chemokines; D014409:Tumor Necrosis Factor-alpha; D014212:Tretinoin; D045726:Metalloproteases; D010196:Pancreatic Elastase